Market by Product Type, Age Group, Distribution Channel, and Country Outlook | Forecast 2022-2028
According to Triton Market
Research’s report, the cough syrup market in Europe is estimated to progress
with a CAGR of 3.20% over the
forecasted period 2022-2028.
Report scope can be customized per your requirements. Request For Customization
The
countries evaluated in the region comprise:
•
The United Kingdom
•
Germany
•
France
•
Spain
•
Italy
•
Rest of Europe
In
Europe, Germany accounts for the majority of the share in the cough syrup
market. The surging
elderly population has increased the burden of respiratory diseases across the
region. Some of the highly prevalent respiratory diseases include asthma,
chronic obstructive pulmonary diseases, respiratory allergies, and pulmonary
hypertension. Over the years, lung cancer has emerged as the leading cause of
death across the region. The high occurrence of asthma and COPD have also
surged in various nations. Thus, the rising number of respiratory conditions
and increasing elderly population create a profitable market for cough syrup.
Chronic obstructive pulmonary disease is highly
prevalent in Germany. According to estimates, around 10-15% of adults are
affected by chronic bronchitis. Moreover, lung disease has emerged as the
fourth major cause of death. Furthermore, the country has a significant elderly
population. Here, bronchiectasis has become a major concern for the elderly
population. Other than this, COPD, asthma, and chronic bronchitis are also
major risks the older population faces. Thus, these factors fuel the cough
syrup market’s growth across Germany.
Air pollution has become a major health concern
for people in the United Kingdom. The rise in air pollution increases the risk
of various conditions, such as asthma, heart disease, lung cancer, etc. As per
estimates, respiratory diseases are the third major cause of death in the
country, including lung cancer, COPD, and pneumonia. Furthermore, around one in
five people are diagnosed with asthma, COPD, or other long-term respiratory
illnesses. Thus, rising respiratory conditions escalate the demand for cough
syrups in the UK.
Cough suppressants are widely used to block
cough reflex, reducing major risks. These suppressants contain dextromethorphan
and antihistamines. These active ingredients help relieve coughs caused by
common cold or other conditions. Several companies provide cough suppressants
to reduce the impact of cough on the body. The
market is examined in terms of product type, distribution channels, and age
group. Based on product type, it is divided into cough
suppressants/antitussives, expectorants, and combination medications.
The
popular companies in the market include Johnson and Johnson, Merck KGaA,
Novartis International AG, Pfizer Inc, Reckitt Benckiser Group Plc, and Sanofi
SA.
Johnson and Johnson is a leading company
involved in researching, developing, manufacturing, and selling healthcare
products. It operates through segments such as consumer, pharmaceutical, and
medical devices. The pharmaceutical segment provides products that help in
various medical fields such as immunology, infectious diseases, neuroscience,
oncology, and pulmonary hypertension, among others. Johnson and Johnson serve
clients across multiple regions, including Europe.
Key deliverables of the report:
●
Market CAGR during the forecasting years 2022-2028
●
Detailed data highlighting key insights, industry components, and
market strategies
● Comprehensive information and estimation of the cough syrup market
revenue growth in Europe and its influence on the parent market
●
In-depth study of forthcoming trends in consumer behavioral
patterns
●
A meticulous analysis of the competitive landscape, vendor
scorecard, and Porter’s Five Forces
● A wide-ranging study of factors that will challenge the Europe
cough syrup market’s growth during the upcoming years
Want to get specific insights? Our team of
analysts can customize this report based on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Offerings, Technolog ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT1. EUROPE
COUGH SYRUP MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE COUGH SYRUP MARKET
2.2. KEY INSIGHTS
2.2.1. INCREASING
DEMAND FOR HERBAL COUGH SYRUPS
2.2.2. COMPANIES
PROVIDE SUGAR-FREE COUGH SYRUPS
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
MARKET STRATEGIES
2.6.1. MERGERS
& ACQUISITIONS
2.6.2. DIVESTITURES
2.7. MARKET
DRIVERS
2.7.1. INCREASING
CHRONIC RESPIRATORY DISEASES
2.7.2. RISE
IN OLDER POPULATION
2.8. MARKET
CHALLENGES
2.8.1. OVERDOSE
RISK
2.8.2. STRICT
GOVERNMENT REGULATIONS AND RESTRICTIONS
2.9. MARKET
OPPORTUNITIES
2.9.1. INCREASE
IN CHILD-FRIENDLY COUGH SYRUP FLAVORS
2.9.2. GROWING
PREFERENCE FOR HOMEOPATHIC COUGH SYRUPS
2.9.3. SPECIAL
PEDIATRIC COUGH SYRUPS
3. EUROPE
COUGH SYRUP MARKET OUTLOOK - BY PRODUCT TYPE
3.1. COUGH
SUPPRESSANTS/ANTITUSSIVES
3.2. COMBINATION
MEDICATIONS
3.3. EXPECTORANTS
4. EUROPE
COUGH SYRUP MARKET OUTLOOK - BY AGE GROUP
4.1. ADULT
4.2. PEDIATRIC
5. EUROPE
COUGH SYRUP MARKET OUTLOOK - BY DISTRIBUTION CHANNEL
5.1. RETAIL
PHARMACY
5.2. HOSPITAL
PHARMACY
5.3. ONLINE
PHARMACY
6. EUROPE
COUGH SYRUP MARKET – COUNTRY OUTLOOK
6.1. UNITED
KINGDOM
6.2. GERMANY
6.3. FRANCE
6.4. SPAIN
6.5. ITALY
6.6. REST
OF EUROPE
7. COMPETITIVE
LANDSCAPE
7.1. ABBOTT
LABORATORIES
7.2. ACELLA
PHARMACEUTICALS LLC
7.3. ASTRAZENECA
PLC
7.4. CIPLA
LIMITED
7.5. DABUR
INDIA LTD
7.6. GLAXOSMITHKLINE
7.7. GLENMARK
PHARMACEUTICALS LIMITED
7.8. JOHNSON
AND JOHNSON
7.9. MERCK
KGAA
7.10. NOVARTIS
INTERNATIONAL AG
7.11. PFIZER
INC
7.12. PROCTOR
AND GAMBLE CO
7.13. RECKITT
BENCKISER GROUP PLC
7.14. SANOFI
SA
7.15. THE
HIMALAYA DRUG COMPANY
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: EUROPE COUGH SYRUP MARKET,
BY COUNTRY, 2022-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: THE COUNTRIES WITH
THE LARGEST PERCENTAGE OF TOTAL POPULATION OVER 65 YEARS IN 2020
TABLE 4: EUROPE COUGH SYRUP
MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 5: EUROPE COUGH SYRUP MARKET,
BY AGE GROUP, 2022-2028 (IN $ MILLION)
TABLE 6: EUROPE COUGH SYRUP MARKET,
BY DISTRIBUTION CHANNEL, 2022-2028 (IN $ MILLION)
TABLE 7: EUROPE COUGH SYRUP
MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
FIGURE
1: MARKET ATTRACTIVENESS INDEX
FIGURE
2: EUROPE COUGH SYRUP MARKET, BY PRODUCT TYPE, 2021 & 2028 (IN %)
FIGURE
3: EUROPE COUGH SYRUP MARKET, BY COUGH SUPPRESSANTS/ANTITUSSIVES, 2022-2028 (IN
$ MILLION)
FIGURE
4: EUROPE COUGH SYRUP MARKET, BY COMBINATION MEDICATIONS, 2022-2028 (IN $
MILLION)
FIGURE
5: EUROPE COUGH SYRUP MARKET, BY EXPECTORANTS, 2022-2028 (IN $ MILLION)
FIGURE
6: EUROPE COUGH SYRUP MARKET, BY AGE GROUP, 2021 & 2028 (IN %)
FIGURE
7: EUROPE COUGH SYRUP MARKET, BY ADULT, 2022-2028 (IN $ MILLION)
FIGURE
8: EUROPE COUGH SYRUP MARKET, BY PEDIATRIC, 2022-2028 (IN $ MILLION)
FIGURE
9: EUROPE COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2021 & 2028 (IN %)
FIGURE
10: EUROPE COUGH SYRUP MARKET, BY RETAIL PHARMACY, 2022-2028 (IN $ MILLION)
FIGURE
11: EUROPE COUGH SYRUP MARKET, BY HOSPITAL PHARMACY, 2022-2028 (IN $ MILLION)
FIGURE
12: EUROPE COUGH SYRUP MARKET, BY ONLINE PHARMACY, 2022-2028 (IN $ MILLION)
FIGURE
13: EUROPE COUGH SYRUP MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE
14: UNITED KINGDOM COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)
FIGURE
15: GERMANY COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)
FIGURE
16: FRANCE COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)
FIGURE
17: SPAIN COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)
FIGURE
18: ITALY COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)
FIGURE
19: REST OF EUROPE COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)